Infographic

Autoimmune diseases are inherently complex due to their numerous and frequently overlapping spectrum of symptoms that can fluctuate within an affected individual, shifting between phases of activity and remission. This can make reaching a conclusive diagnosis, and prescribing the correct medication, exceedingly difficult, potentially resulting in a patient failing to receive the right treatment in a timely manner.

With an estimated 1 in 6 Americans affected by some form of autoimmune disease, it is now imperative that better diagnostics are developed to alleviate not only the sizable financial strain on healthcare systems, but to ensure that patients receive the correct diagnosis. Thankfully, biological marker systems are already being developed to help unravel symptom complexity and stratify patients. Companion diagnostics and disease-specific biomarkers can then be implemented to identify individual diseases and give clinicians the power to ensure patients receive the right medicine. These developments are ushering in an era of personalized medicine that will facilitate an early diagnosis and rapid treatment for those suffering with autoimmune disease.

Autoimmune diseases are inherently complex due to their numerous and frequently overlapping spectrum of symptoms that can fluctuate within an affected individual, shifting between phases of activity and remission. This can make reaching a conclusive diagnosis, and prescribing the correct medication, exceedingly difficult, potentially resulting in a patient failing to receive the right treatment in a timely manner.

With an estimated 1 in 6 Americans affected by some form of autoimmune disease, it is now imperative that better diagnostics are developed to alleviate not only the sizable financial strain on healthcare systems, but to ensure that patients receive the correct diagnosis. Thankfully, biological marker systems are already being developed to help unravel symptom complexity and stratify patients. Companion diagnostics and disease-specific biomarkers can then be implemented to identify individual diseases and give clinicians the power to ensure patients receive the right medicine. These developments are ushering in an era of personalized medicine that will facilitate an early diagnosis and rapid treatment for those suffering with autoimmune disease.

Protagen-infographic

Click Image to download high resolution PDF file.